Hide Board Information

Show Board Information

Qmc Quantum Minerals Corp QMCQF

Board Mod: ipoguy1

Asst Mods:

Last Post: 03/22/2021 8:50:47 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 2

QMCQF Quantum Minerals Corp. (QMC.V)

[url=https://youtu.be/w3CrFR1Jk1w[/url]

Qmc Quantum Minerals Corp (OTCMRKTS: QMCQF) Stock Message Board

1. QMCQF Company Profile

    

2. QMCQF Time & Sales

    

3. QMCQF Recent News

    

4. QMCQF Filings

    

5. QMCQF Financials

    

6. QMCQF Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

5	QMCQF/QMC.V Quantum Minerals	ipoguy1	06/05/2017 9:18:48 AM
4	PRESS RELEASE QMC Quantum to Acquire Former Igron	Uptick Network	10/17/2016 12:29:28 PM
3	QMCQF Exciting News For Quantum Minerals Corp.	ipoguy1	10/13/2016 10:36:47 AM
2	QMCQF & QMC.V On Harvest	ipoguy1	10/10/2016 12:11:48 PM
1	OTC MARKETS COMPANY PROFILE QMCQF/ QMV.V Quantum	ipoguy1	10/07/2016 10:53:05 AM

Newer

Recent Articles

• Investing in Education for a Sustainable Peaceful Future
• Blumenthal Nordrehaug Bhowmik De Blouw LLP Takes Action Against Greenwaste Recycling
• Soshiro Hoshina Joins Kaiju No. 8 Game: Exciting New Update
• The $100,000 H-1B Visa Fee: Implications on Tech Giants
• Teva's Olanzapine LAI Study Highlights Safety and Efficacy
• AUSTEDO XR: Improving Lives Through Symptom Management
• Teva's New Olanzapine LAI Offers Long-Term Safety for Schizophrenia
• Floyd Mayweather Jr. Faces $1.2M Lawsuit From Vegas Auto Gallery
• Elon Musk Envisions a Future with Robot-Empowered Abundance
• Reflections on Leadership and Change in America Today
• A Historic Week of Changes and Challenges in America
• Freedom Plaza's Vision: A Transformational Affordable Housing Project
• MTL Cannabis Corp. Secures $2 Million in Recent Offering
• Freedom Plaza Pledges Complete Affordable Housing Commitment
• Fluor Corporation Faces Securities Class Action – Investors Alert
• Ex-Trump Lawyer Compares Kimmel Suspension to Historical Censorship
• The Speedy Job Hunt: How Fast Applications Led to Success
• Exploring the Decline in Donald Trump's Approval Ratings
• Strategic Shifts in AI: How Trump's Actions Redefine America
• MAGACOIN FINANCE Surges with Impressive Presale Success
• Revolutionizing Trading with Bravo Flowdex: A 2025 Perspective
• Discover Bravo Flowdex: Your AI Trading Solution in 2025
• Unlocking Trading Potential with Next-Gen Net Rowdex AI
• Ricardo Salinas Pliego's Bold Bitcoin Stance Against Fiat
• Kiyosaki Critiques Funds, Supports Trump's Move for Investors
• MAGACOIN FINANCE Emerges as a Significant Player in Crypto
• Unveiling the Cutting-Edge Technology of Immediate Edge Trading
• uCloudlink Launches PetPhone to Revolutionize Pet Care
• Investors Invited to Join Securities Fraud Lawsuit against SPPI
• Charlie Kirk's Final Thoughts on Success and Entrepreneurship
• Tracer's Innovative IEO Launch on Coinstore Revolutionizes Carbon Market
• Goldragon Transforms GameFi with Innovative Staking and Governance
• Convenience Stores Challenge Fast-Food Chains for Breakfast Sales
• Essential Guidance for Families in Interpleader Lawsuits
• Sasken and VicOne Unite for Cutting-Edge Automotive Security
• Investors Can Lead Tronox Holdings plc Class Action Lawsuit
• Investors Review V.F. Corporation Class Action Lawsuit Insights
• Sasken and VicOne Unite for Advanced Automotive Security Solutions
• A Deep Dive into AI Growth and Its Impact on Industries
• Trump's Shift on Taiwan Military Support: Implications Ahead
• Navigating the Frontier of Artificial Superintelligence
• Discover AIMOON: A New Era in AI and Web3 Interactions
• Investors of V.F. Corporation Can Pursue Class Action Claims
• Farm Aid 40: Honoring Legacy and Addressing Future Challenges
• Flying Taxi Market Warriors: Who Will Dominate the Sky?
• VAPORESSO's XROS PRO 2: A New Era for Vaping Excellence
• Senate Standoff: Shifting Dynamics and Government Shutdown Risk
• Celebrating Heritage: Spencer Tunick's Art for 100 Years of Alhambra
• VAPORESSO Unveils Cutting-Edge XROS PRO 2 for Vaping Enthusiasts
• C4 Therapeutics Unveils Exciting Cemsidomide Data for Myeloma